Company intelligence / Profile preview
Topix Pharmaceuticals
- Ownership
- Private
- Development stage
- Other
Overview
Topix Pharmaceuticals is a leading provider of medical-grade skincare products for dermatologists and physicians. Their portfolio includes science-backed topical formulations targeting anti-aging, brightening, acne, and other dermatological concerns. The company emphasizes proprietary ingredients such as highly purified green tea polyphenols and stable L-Ascorbic Acid. They have recently partnered with the University of Minnesota to develop ProteXidine™, a novel biomimetic decoy molecule for advanced skin protection[5].
- Therapeutic areas
- DermatologyOther
- Modalities
- Small molecule (topical actives such as retinol, glycolic acid, salicylic acid)Biologic (antioxidants like green tea polyphenols)
- Industry
- Biotech
Drug pipeline
5 assets4 more assets in the full pipeline.
Partnerships
Beyond the preview
Go deeper on Topix Pharmaceuticals.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Topix Pharmaceuticals.